Endurx Pharmaceuticals Inc.
Tucson, AZ
- UEI
- KWKNEAQPAK43
- CAGE
- 6V7G0
- Primary NAICS
- 541713 Research and Development in Nanotechnology
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- Other NAICS codes in SAM.gov
- SAM.gov registration date
- Physical address
- 3942 Guaymas Pl, Tucson, AZ 85711, USA
- Website
- endurxpharm.com
- Founded
- 2013
- Employees
- 1-10
- Estimated annual revenue
- $0-$1M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of a novel tumor-targeting and tumor-penetrating nanosystem for breast cancer therapy | Defense Health Agency | $1,412,302 | |
| A novel targeted delivery system for cancer treatment and diagnosis | National Institutes of Health | $1,709,711 |
Quick answers
Is Endurx Pharmaceuticals Inc. registered in SAM.gov?
Yes. Endurx Pharmaceuticals Inc.'s SAM.gov registration is active through January 13, 2027.
What is Endurx Pharmaceuticals Inc.'s most recent federal award?
Endurx Pharmaceuticals Inc.'s most recent federal grant award is Development of a novel tumor-targeting and tumor-penetrating nanosystem for breast cancer therapy (W81XWH2010122), from Defense Health Agency, on March 1, 2020.
On GovTribe
See Endurx Pharmaceuticals Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors